Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600161'
s Days Inventory Range Over the Past 10 Years
Min: 359.29 Med: 392.68 Max: 448.4
Current: 419.95
During the past 13 years, Beijing Tiantan Biological Products's highest Days Inventory was 448.40. The lowest was 359.29. And the median was 392.68.
SHSE:600161's Days Inventory is ranked worse than 78.84% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:600161: 419.95
Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Tiantan Biological Products's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Tiantan Biological Products's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 3.58.
Beijing Tiantan Biological Products (SHSE:600161) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Beijing Tiantan Biological Products's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beijing Tiantan Biological Products's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Beijing Tiantan Biological Products Days Inventory Related Terms
Beijing Tiantan Biological Products Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products Days Inventory Chart
SHSE:600161 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Beijing Tiantan Biological Products's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tiantan Biological Products Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Days Inventory distribution charts can be found below:
* The bar in red indicates where Beijing Tiantan Biological Products's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tiantan Biological Products (SHSE:600161) has a Days Inventory of 499.14 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Tiantan Biological Products and its competitors. This is 27% above median its historical median of 392.68. Over the past decade, Beijing Tiantan Biological Products' Days Inventory has ranged from 359.29 to 448.40. According to the industry distribution chart, Beijing Tiantan Biological Products ranks #503 out of 638 companies in the Biotechnology industry, placing it in the top 78.8%.
Is Beijing Tiantan Biological Products' Days Inventory too high?
Beijing Tiantan Biological Products' current Days Inventory of 499.14 is 27% above median its 10-year median of 392.68. Over the past 10 years, this metric has ranged from a low of 359.29 to a high of 448.40. The Biotechnology industry median Days Inventory is 183.20. Beijing Tiantan Biological Products' value of 499.14 is 172.5% above this industry median. Based on the distribution chart, Beijing Tiantan Biological Products ranks #503 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Beijing Tiantan Biological Products has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tiantan Biological Products' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tiantan Biological Products ranks #503 out of 638 companies for Days Inventory. This places Beijing Tiantan Biological Products in the lower half of its industry. The industry median Days Inventory is 183.20. Beijing Tiantan Biological Products' value of 499.14 is 172.5% above this benchmark. Historically, Beijing Tiantan Biological Products' own Days Inventory has ranged from 359.29 to 448.40 over the past decade. While the company's 10-year median is 392.68 vs. the industry median of 183.20, Beijing Tiantan Biological Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tiantan Biological Products's current Days Inventory of 499.14 is 172.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beijing Tiantan Biological Products and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tiantan Biological Products's current Days Inventory is 499.14, which is 27% above median its own 10-year median of 392.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tiantan Biological Products stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products (SHSE:600161) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥23.94, compared to a current price of ¥12.95 — trading 45.9% below its estimated fair value. The current Days Inventory is 499.14, which is 27% above median its 10-year median of 392.68 and 172.5% above the Biotechnology industry median of 183.20. Beijing Tiantan Biological Products' overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Beijing Tiantan Biological Products (SHSE:600161), the current Days Inventory is 499.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tiantan Biological Products (SHSE:600161) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tiantan Biological Products stock appears to be undervalued.
The current stock price of ¥12.95 is trading 45.9% below its estimated GF Value™ of ¥23.94.
GuruFocus considers Beijing Tiantan Biological Products to be Significantly Undervalued.
Key valuation signals for SHSE:600161:
Days Inventory: 499.14 (27% above median its 10-year median of 392.68)
GF Value™: ¥23.94 vs. price of ¥12.95 (45.9% below fair value)
Industry Position: 172.5% above the Biotechnology median (#503 of 638)
No single metric tells the full story. See the SHSE:600161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tiantan Biological Products Business Description
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business. The company's main products include human albumin, human immunoglobulin (pH4) for intravenous injection, human hepatitis B immunoglobulin, human immunoglobulin, human rabies immunoglobulin, human histamine immunoglobulin, and others.
75GF Score
Get the complete analysis for SHSE:600161
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600161 has been successfully added to your 
